Dissemin is shutting down on January 1st, 2025

Published in

Oxford University Press, British Journal of Surgery, 2(101), p. 114-119, 2013

DOI: 10.1002/bjs.9366

Links

Tools

Export citation

Search in Google Scholar

Splenic vein thrombosis and pancreatic fistula after minimally invasive distal pancreatectomy

Journal article published in 2013 by C. M. Kang, Y. E. Chung, M. J. Jung, H. K. Hwang ORCID, S. H. Choi, W. J. Lee
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Abstract Background This study aimed to investigate the clinical relevance of splenic vein thrombosis (SVT) in the splenic vein remnant following minimally invasive distal pancreatosplenectomy (DPS). Methods Medical records of patients who underwent laparoscopic or robotic distal pancreatectomy (DP) with or without splenectomy between January 2006 and August 2012 were reviewed. Rates of SVT and clinically relevant postoperative pancreatic fistula (POPF) were compared in a group of patients undergoing DPS and a group having spleen-preserving DP. Results Seventy-nine patients had minimally invasive DP, of whom 38 (48 per cent) developed SVT in the splenic vein remnant. DPS was associated with POPF (P = 0·001) and SVT (P < 0·001). SVT length was closely related to the amount of peripancreatic fluid collection (P = 0·025) and POPF (P = 0·045). In a comparison of splenic vessel-sacrificing, spleen-preserving DP and DPS, postoperative platelet count was significantly higher in the DPS group (P < 0·001). In addition, grade of SVT (P = 0·092) and POPF (P = 0·065) tended to be associated with DPS, suggesting that SVT may be related to both splenectomy and POPF. Conclusion Minimally invasive DPS is associated with SVT and POPF. Preservation of the spleen should be considered when treating patients with benign and borderline malignant tumours of the distal pancreas.